Overbrook Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Overbrook Management's LLY Position: Q3 2026 in Review
Overbrook Management reduced its Eli Lilly (LLY) stake by 0.02% in Q3 2026, selling an estimated $8.26K and leaving 29,359 shares worth $34M. The position accounts for 5.28% of the portfolio, ranked #6.
Overbrook Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $35.2M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Overbrook Management held 29,359 shares of Eli Lilly worth $34M as of Q3 2026.
- Overbrook Management sold 7 Eli Lilly shares in Q3 2026, an estimated $8.26K.
- Eli Lilly made up 5.28% of Overbrook Management's portfolio in Q3 2026, its #6 holding.
- Overbrook Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- Overbrook Management's Eli Lilly position peaked at $35.2M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Overbrook Management's 13F filing for Q3 2026, filed 8 Oct 2026.